Sign inJoin waitlistJoin the waitlist

Judith Tsui

Program Director · University of Washington School of Medicine

Credentials: · · · · · · ·

History

University of Washington School of Medicine
Present
Co-Investigator · University of Washington School of Medicine
Present
UW/Fred Hutch Center for AIDS Research (CFAR) Substance Use Scientific Working Group · University of Washington School of Medicine
Present

University of California-San Francisco
2004–2008
University of California
Internal Medicine
Oregon Health & Science University
1997–2000
Epidemiology), Rollins School or Public Health, Emory University Atlanta, GA
New York University Grossman School of Medicine
1993–1997
Anthropology), Princeton University, Princeton, NJ
1987–1991

Research

Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial
JAMA Internal Medicine · 2014 · 292 citations
Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs…
Gastroenterology · 2016 · 189 citations
Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users
JAMA Internal Medicine · 2014 · First of 5 authors · 181 citations

Jeffrey Samet
52 papers
Judith Feinberg
41 papers
Arthur Kim
24 papers
Paula Lum
23 papers
Alain Litwin
22 papers
Elenore Bhatraju
22 papers
BN
Brianna Norton
21 papers
TK
Todd Korthuis
21 papers
Jane Liebschutz
20 papers
Joseph Merrill
20 papers
Julia Arnsten
20 papers
Peter Friedmann
19 papers

Grants

Adapting and Scaling Patient-Centered Collaborative Care Delivery Models to Offer Treatment for Substance Use Disorders and Hepatitis C
National Institute on Drug Abuse · K24
Contact PI · $177.9K · University of Washington
2026–2031
ARCH REACH: ARCH Center for Research at the Intersection of Equity, Alcohol, Community and HIV
National Institute on Alcohol Abuse and Alcoholism · P60
Project lead · $283.2K · University of Washington
2026–2031
Improving the Transition to Outpatient Opioid Use Disorder Treatment Through Patient Navigation Plus Remote mHealth Adherence Support for Patients Initiated on Buprenorphine in the Hospital
National Institute on Drug Abuse · R01
Contact PI · $668.9K · University of Washington
2026–2031
Implementing HIV Screening and Prevention in Low-Barrier Office-Based Opioid Treatment (OBOT) Programs to End the HIV Epidemic
National Institute on Drug Abuse · R01
Contact PI · $672.7K · University of Washington
2026–2030

Clinical trials

Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
Principal investigator · Recruiting
University of Washington
2026–2029
MHealth Incentivized Adherence Plus Patient Navigation
Principal investigator · Completed
University of Washington
2024–2025
Hepatitis C Pharmacy-based Strategy for Injectors
Principal investigator · Completed
University of Washington
2020–2023
Trial of Adherence App for Buprenorphine Treatment (TAAB) Study
Principal investigator · Completed
University of Washington
2019–2020